Esophageal stricture overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
 
{{Esophageal stricture}}
{{CMG}}; {{AE}}{{MA}}  
{{CMG}}; {{AE}}{{MA}}  
{{Esophageal stricture}}
==Overview==
==Overview==
It is thought that esophageal stricture is the result of lower pressure of [[esophageal sphincter]] in [[gastroesophageal reflux disease]], esophageal motor disorder, [[inflammation]] and [[fibrosis]] in [[neoplasia]]. Common causes of esophageal stricture include [[gastroesophageal reflux disease]] and [[caustic]] ingestions. Overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the [[prevalence]] of esophageal stricture is approximately 70-120 per 100,000 individuals in united states.The most potent [[risk factor]] in the development of esophageal stricture is frequent [[acid reflux]]. Esophageal stricture is diagnosed based on history of [[dysphagia]] and diagnostic studies such as barium [[Esophagogram|esophagography]], [[esophagogastroduodenoscopy]], [[endoscopic ultrasound]], [[manometry]]. [[Pharmacologic]] medical therapy for esophageal stricture secondary to [[gastroesophageal reflux disease]] includes [[Proton pump inhibitor|proton pump inhibitors]] or [[Histamine-2 receptor blocker|H2 antagonists]]. The mainstay of treatment for esophageal stricture is [[dilation]]. Self-expandable plastic or [[Stent|metal stents]] placement is indicated for patients with refractory esophageal stricture. [[Surgery]] is usually reserved for patients with either inability to dilate the stricture, frequent recurrence of [[dysphagia]], extraesophageal manifestations and long term [[side effects]] of medical therapy.
Esophageal stricture is the result of increased pressure of lower [[esophageal sphincter]]. It is associated with disorders such as [[gastroesophageal reflux disease]], esophageal motor disorders, [[inflammation]] and [[fibrosis]] in [[neoplasia]]. Common causes of esophageal stricture include [[gastroesophageal reflux disease]] and [[caustic]] ingestions. Overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the [[prevalence]] of esophageal stricture is approximately 70-120 per 100,000 individuals in united states.The most potent [[risk factor]] in the development of esophageal stricture is frequent [[acid reflux]]. Esophageal stricture is diagnosed based on history of [[dysphagia]] and diagnostic studies such as barium [[Esophagogram|esophagography]], [[esophagogastroduodenoscopy]], [[endoscopic ultrasound]], and [[manometry]]. [[Pharmacologic]] medical therapy for esophageal stricture secondary to [[gastroesophageal reflux disease]] includes [[Proton pump inhibitor|proton pump inhibitors]] or [[Histamine-2 receptor blocker|H2 antagonists]]. The mainstay of treatment for esophageal stricture is [[dilation]]. Self-expandable plastic or [[Stent|metal stents]] placement is indicated for patients with refractory esophageal stricture. [[Surgery]] is usually reserved for patients with either inability to dilate the stricture, frequent recurrence of [[dysphagia]], extraesophageal manifestations and long term [[side effects]] of medical therapy.


==Historical Perspective==
==Historical Perspective==
First intervention for esophageal stricture was done in the 17 century by whalebone. The first bougienage was performed in 1801. In 1868, esophagoscope was developed for the first time. In 1877, first surgical [[resection]] for [[Esophageal cancer|esophageal carcinoma]] was performed by Vincenz Czerny. The first stent was introduced in 1990.
The first intervention for esophageal stricture was done in the 17th century by Whalebone. The first bougienage was performed in 1801. In 1868, esophagoscope was developed for the first time. In 1877, first surgical [[resection]] for [[Esophageal cancer|esophageal carcinoma]] was performed by Vincenz Czerny. The first stent was introduced in 1990.


==Classification==
==Classification==
Line 14: Line 12:


==Pathophysiology==
==Pathophysiology==
It is thought that esophageal stricture is the result of lower pressure of [[esophageal sphincter]] in [[gastroesophageal reflux disease]], esophageal motor disorder, [[inflammation]] and [[fibrosis]] in [[neoplasia]]. The most characteristic finding in [[gross pathology]] is thickening of the lower [[esophageal]] wall in [[gastroesophageal reflux disease]], pale [[mucosa]] in [[lymphocytic]] [[esophagitis]] and [[hemorrhagic]] [[congestion]] in [[caustic]] ingestion.
Esophageal stricture is the result of lower pressure of [[esophageal sphincter]] in [[gastroesophageal reflux disease]], esophageal motor disorder, [[inflammation]] and [[fibrosis]] in [[neoplasia]]. The most characteristic finding in [[gross pathology]] is thickening of the lower [[esophageal]] wall in [[gastroesophageal reflux disease]], a pale [[mucosa]] in [[lymphocytic]] [[esophagitis]] and [[hemorrhagic]] [[congestion]] in [[caustic]] ingestion. [[Microscopic]] [[histopathological]] characteristic findings of esophageal stricture is intraepithelial [[lymphocytes|lymphocytosis]][[basal cell]] [[hyperplasia]] in [[gastroesophageal reflux disease]], [[T lymphocytes]] infiltration in [[squamous]] [[mucosa]] in [[lymphocytic]] [[esophagitis]] and [[eosinophilic]] [[necrosis]] in [[caustic]] ingestion
 
[[Microscopic]] [[histopathological]] characteristic findings of esophageal stricture is inntraepithelial [[lymphocytes]] and [[basal cell]] [[hyperplasia]] in [[gastroesophageal reflux disease]], [[Infiltration (medical)|infiltration]] [[T lymphocytes]] in [[squamous]] [[mucosa]] in [[lymphocytic]] [[esophagitis]] and [[eosinophilic]] [[necrosis]] in [[caustic]] ingestion


==Causes==
==Causes==
Line 22: Line 18:


==Differentiating  esophageal stricture from Other Diseases==
==Differentiating  esophageal stricture from Other Diseases==
Esophageal stricture must be differentiated from plummer-vinson syndrome, [[achalasia]] , [[diffuse esophageal spasm]], [[systemic sclerosis]], [[zenker's diverticulum]], [[Esophageal cancer|esophageal carcinoma]], [[stroke]], motor disorders, [[GERD]][[Esophageal web|, esophageal web]].
Esophageal stricture must be differentiated from [[Plummer-Vinson syndrome]], [[achalasia]], [[diffuse esophageal spasm]], [[systemic sclerosis]], [[zenker's diverticulum]], [[Esophageal cancer|esophageal carcinoma]], [[stroke]], motor disorders such as [[Myasthenia Gravis]], [[GERD]][[Esophageal web|, esophageal web]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Most of the esophageal strictures are related to [[gastroesophageal reflux disease]]. The overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the [[prevalence]] of esophageal stricture is approximately 70-120 per 100,000 individuals in united states. The [[incidence]] of esophageal stricture increases with age. There is no racial predilection to esophageal stricture. The risk of esophageal stricture is higher in men under 60 yr but there is similar [[incidence]] in men and women after age 60.
Most of the esophageal strictures are related to [[gastroesophageal reflux disease]]. The overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the [[prevalence]] of esophageal stricture is approximately 70-120 per 100,000 individuals in united states. The [[incidence]] of esophageal stricture increases with age. There is no racial predilection to esophageal stricture. The risk of esophageal stricture is higher in men under 60 years but there is similar [[incidence]] in men and women after age 60.


==Risk Factors==
==Risk Factors==
Line 34: Line 30:


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
If left untreated, patients with esophageal stricture may progress to develop [[pulmonary aspiration]], [[weight loss]], and [[dehydration]]. Common [[complication]]<nowiki/>s of esophageal stricture include [[perforation]], [[bleeding]], [[pneumonia]][[bacteremia]]. [[Prognosis]] is generally good but recurrence of symptoms after [[dilation]] are prevalent and usually recurrent [[dilation]] is necessary.
If left untreated, patients with esophageal stricture may progress to develop [[pulmonary aspiration]], [[weight loss]], and [[dehydration]]. Common [[Complications|complication<nowiki/>s]] of esophageal stricture include [[perforation]], [[bleeding]], [[pneumonia]] and [[bacteremia]]. [[Prognosis]] is generally good but recurrence of symptoms after [[dilation]] are prevalent and usually recurrent [[dilation]] is necessary.
 
 
==Diagnosis==
==Diagnosis==
===Diagnostic study of choice===
===Diagnostic study of choice===
Esophageal stricture is diagnosed based on history of [[dysphagia]] and diagnostic studies such as barium [[Esophagogram|esophagography]], [[esophagogastroduodenoscopy]], [[endoscopic ultrasound]][[manometry]].
Esophageal stricture is diagnosed based on history of [[dysphagia]] and diagnostic studies such as barium [[Esophagogram|esophagography]], [[esophagogastroduodenoscopy]], [[endoscopic ultrasound]] and [[manometry]].


===History and Symptoms===
===History and Symptoms===
Line 45: Line 39:


===Physical Examination===
===Physical Examination===
Patients with esophageal stricture can usually appear normal. [[Cachexia]] and [[pallor]] are notable in patients with esophageal stricture due to [[malignant]] causes.
Patients with esophageal stricture can usually appear normal. [[Cachexia]] and [[pallor]] are notable in patients with esophageal stricture due to neoplastic causes.


===Laboratory Findings===
===Laboratory Findings===
Laboratory findings are usually normal among patients with esophageal stricture although [[anemia]] may be seen with [[malignant]] causes of esophageal stricture. Other possible laboratory tests are high serum [[gastrin]] level in [[Zollinger-Ellison syndrome|zollinger ellison syndrome]] and peripheral [[eosinophilia]] in [[eosinophilic esophagitis]] as causes of esophageal stricture.
Laboratory findings are usually normal among patients with esophageal stricture although [[anemia]] may be seen with neoplastic causes of esophageal stricture. Other possible laboratory tests are high serum [[gastrin]] level in [[Zollinger-Ellison syndrome|zollinger ellison syndrome]] and peripheral [[eosinophilia]] in [[eosinophilic esophagitis]] as causes of esophageal stricture.


===Electrocardiogram===
===Electrocardiogram===
Line 66: Line 60:


===Other Imaging Findings===
===Other Imaging Findings===
Barium [[Esophagogram|esophagography]] is helpful in the diagnosis of esophageal stricture. Findings on a barium [[esophagogram]] suggestive of [[benign]] esophageal stricture include concentric narrowing, smoothly tapering and eccentric narrowing, abrupt, asymmetric in [[malignant]] causes.
Barium [[Esophagogram|esophagography]] is helpful in the diagnosis of esophageal stricture. Findings on a barium [[esophagogram]] suggestive of [[benign]] esophageal stricture include concentric narrowing and smooth tapering. Eccentric narrowing, abrupt and asymmetric narrowing are suggestive of [[malignant]] causes.


===Other Diagnostic Studies===
===Other Diagnostic Studies===
Other diagnostic study for esophageal stricture include [[esophagogastroduodenoscopy]] (EGD) for detection [[malignant]] causes. [[Manometry]] is used in cases of esophageal stricture due to dysmotility.
Other diagnostic studies for esophageal stricture include [[esophagogastroduodenoscopy]] (EGD) for detection [[malignant]] causes. [[Manometry]] is used in cases of esophageal stricture due to dysmotility.


==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
 [[Pharmacologic]] medical therapy for esophageal stricture secondary to [[gastroesophageal reflux disease]] includes [[Proton pump inhibitor|proton pump inhibitors]] or [[Histamine-2 receptor blocker|H2 antagonists]]. Patients are advised to consider life style modification for [[gastroesophageal reflux disease]].
[[Pharmacologic]] medical therapy for esophageal stricture secondary to [[gastroesophageal reflux disease]] includes [[Proton pump inhibitor|proton pump inhibitors]] or [[Histamine-2 receptor blocker|H2 antagonists]]. Patients are advised to consider life style modification for [[gastroesophageal reflux disease]].
===Surgery===
===Surgery===
==== Procedure ====
The mainstay of treatment for esophageal stricture is [[dilation]]. Self-expandable plastic or [[Stent|metal stents]] placement is indicated for patients with refractory esophageal stricture.  
The mainstay of treatment for esophageal stricture is [[dilation]]. Self-expandable plastic or [[Stent|metal stents]] placement is indicated for patients with refractory esophageal stricture.  


==== surgical management ====
[[Surgery]] is usually reserved for patients with either inability to dilate the [[stricture]], frequent recurrence of [[dysphagia]], extraesophageal manifestations and long term [[side effects]] of medical therapy
 [[Surgery]] is usually reserved for patients with either inability to dilate the [[stricture]], frequent recurrence of [[dysphagia]], extraesophageal manifestations and long term [[side effects]] of medical therapy
=== Primary Prevention ===
=== Primary Prevention ===
Effective measures for the [[primary prevention]] of esophageal stricture include treatment and life style modification for [[gastroesophageal reflux disease]], taking pills with a full glass of water and storing all [[corrosive]] chemicals.
Effective measures for the [[primary prevention]] of esophageal stricture include treatment and life style modification for [[gastroesophageal reflux disease]], taking pills with a full glass of water and storing all [[corrosive]] chemicals.


===Secondary Prevention===
===Secondary Prevention===
Effective measures for the secondary prevention of esophageal stricture include lifestyle modification, [[Proton pump inhibitor|proton pump inhibitors]] or [[Histamine-2 receptor blocker|H2 antagonists]].<gallery>
Effective measures for the secondary prevention of esophageal stricture include lifestyle modification, [[Proton pump inhibitor|proton pump inhibitors]] or [[Histamine-2 receptor blocker|H2 antagonists]].
Image:
 
Esophageal-stricture-001.jpg
 
Image:


Esophageal-stricture-002.jpg
Image:
Esophageal-stricture-003.jpg
</gallery>
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Gastroenterology]]
[[Category:Medicine]]
[[Category:Up-To-Date]]

Latest revision as of 21:41, 29 July 2020

Esophageal stricture Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophageal stricture from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Procedure
Surgical Management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal stricture overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal stricture overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal stricture overview

CDC on Esophageal stricture overview

Esophageal stricture overview in the news

Blogs on Esophageal stricture overview

Directions to Hospitals Treating Esophageal stricture

Risk calculators and risk factors for Esophageal stricture overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

Esophageal stricture is the result of increased pressure of lower esophageal sphincter. It is associated with disorders such as gastroesophageal reflux disease, esophageal motor disorders, inflammation and fibrosis in neoplasia. Common causes of esophageal stricture include gastroesophageal reflux disease and caustic ingestions. Overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the prevalence of esophageal stricture is approximately 70-120 per 100,000 individuals in united states.The most potent risk factor in the development of esophageal stricture is frequent acid reflux. Esophageal stricture is diagnosed based on history of dysphagia and diagnostic studies such as barium esophagographyesophagogastroduodenoscopyendoscopic ultrasound, and manometry. Pharmacologic medical therapy for esophageal stricture secondary to gastroesophageal reflux disease includes proton pump inhibitors or H2 antagonists. The mainstay of treatment for esophageal stricture is dilation. Self-expandable plastic or metal stents placement is indicated for patients with refractory esophageal stricture. Surgery is usually reserved for patients with either inability to dilate the stricture, frequent recurrence of dysphagia, extraesophageal manifestations and long term side effects of medical therapy.

Historical Perspective

The first intervention for esophageal stricture was done in the 17th century by Whalebone. The first bougienage was performed in 1801. In 1868, esophagoscope was developed for the first time. In 1877, first surgical resection for esophageal carcinoma was performed by Vincenz Czerny. The first stent was introduced in 1990.

Classification

There is no established system for the classification of esophageal stricture, but it may be classified into benign and malignant according to causes.

Pathophysiology

Esophageal stricture is the result of lower pressure of esophageal sphincter in gastroesophageal reflux disease, esophageal motor disorder, inflammation and fibrosis in neoplasia. The most characteristic finding in gross pathology is thickening of the lower esophageal wall in gastroesophageal reflux disease, a pale mucosa in lymphocytic esophagitis and hemorrhagic congestion in caustic ingestion. Microscopic histopathological characteristic findings of esophageal stricture is intraepithelial lymphocytosisbasal cell hyperplasia in gastroesophageal reflux diseaseT lymphocytes infiltration in squamous mucosa in lymphocytic esophagitis and eosinophilic necrosis in caustic ingestion

Causes

Common causes of esophageal stricture include gastroesophageal reflux disease and caustic ingestions.

Differentiating esophageal stricture from Other Diseases

Esophageal stricture must be differentiated from Plummer-Vinson syndromeachalasia, diffuse esophageal spasmsystemic sclerosiszenker's diverticulumesophageal carcinomastroke, motor disorders such as Myasthenia GravisGERD, esophageal web.

Epidemiology and Demographics

Most of the esophageal strictures are related to gastroesophageal reflux disease. The overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the prevalence of esophageal stricture is approximately 70-120 per 100,000 individuals in united states. The incidence of esophageal stricture increases with age. There is no racial predilection to esophageal stricture. The risk of esophageal stricture is higher in men under 60 years but there is similar incidence in men and women after age 60.

Risk Factors

The most potent risk factor in the development of esophageal stricture is frequent acid reflux. Other risk factors include hiatal herniaobesitysmokingesophageal dysmotility, increased gastric acidity, and heavy alcohol use.

Screening

There is insufficient evidence to recommend routine screening for esophageal stricture.

Natural History, Complications, and Prognosis

If left untreated, patients with esophageal stricture may progress to develop pulmonary aspirationweight loss, and dehydration. Common complications of esophageal stricture include perforationbleedingpneumonia and bacteremiaPrognosis is generally good but recurrence of symptoms after dilation are prevalent and usually recurrent dilation is necessary.

Diagnosis

Diagnostic study of choice

Esophageal stricture is diagnosed based on history of dysphagia and diagnostic studies such as barium esophagographyesophagogastroduodenoscopyendoscopic ultrasound and manometry.

History and Symptoms

The hallmark of esophageal stricture is dysphagia . A positive history of heartburn is suggestive of esophageal stricture. The most common symptoms of esophageal stricture include dysphagiaodynophagia, and heartburn. Less common symptoms of esophageal stricture include chronic cough and wheezing.

Physical Examination

Patients with esophageal stricture can usually appear normal. Cachexia and pallor are notable in patients with esophageal stricture due to neoplastic causes.

Laboratory Findings

Laboratory findings are usually normal among patients with esophageal stricture although anemia may be seen with neoplastic causes of esophageal stricture. Other possible laboratory tests are high serum gastrin level in zollinger ellison syndrome and peripheral eosinophilia in eosinophilic esophagitis as causes of esophageal stricture.

Electrocardiogram

There are no ECG findings associated with esophageal stricture.

X-ray

chest x-ray may be helpful in the diagnosis of tumors as a cause of esophageal stricture.

CT scan

Chest CT scan may be helpful in the diagnosis of malignant causes of esophageal stricture.

MRI

In general MRI has not been routinely recommended for esophageal stricture.

Echocardiography or Ultrasound

There are no echocardiography findings associated with esophageal stricture. Endoscopic ultrasound may be helpful in the diagnosis of malignant causes of esophageal stricture.

Other Imaging Findings

Barium esophagography is helpful in the diagnosis of esophageal stricture. Findings on a barium esophagogram suggestive of benign esophageal stricture include concentric narrowing and smooth tapering. Eccentric narrowing, abrupt and asymmetric narrowing are suggestive of malignant causes.

Other Diagnostic Studies

Other diagnostic studies for esophageal stricture include esophagogastroduodenoscopy (EGD) for detection malignant causes. Manometry is used in cases of esophageal stricture due to dysmotility.

Treatment

Medical Therapy

Pharmacologic medical therapy for esophageal stricture secondary to gastroesophageal reflux disease includes proton pump inhibitors or H2 antagonists. Patients are advised to consider life style modification for gastroesophageal reflux disease.

Surgery

The mainstay of treatment for esophageal stricture is dilation. Self-expandable plastic or metal stents placement is indicated for patients with refractory esophageal stricture.

Surgery is usually reserved for patients with either inability to dilate the stricture, frequent recurrence of dysphagia, extraesophageal manifestations and long term side effects of medical therapy

Primary Prevention

Effective measures for the primary prevention of esophageal stricture include treatment and life style modification for gastroesophageal reflux disease, taking pills with a full glass of water and storing all corrosive chemicals.

Secondary Prevention

Effective measures for the secondary prevention of esophageal stricture include lifestyle modification, proton pump inhibitors or H2 antagonists.

References

Template:WH Template:WS